Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Costalonga, Elerson C ^a   Silva, Filipe M O ^a   Noronha, Irene L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; VALPROIC ACID; ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; INFLAMMATION; KIDNEY DISEASE; MALE; NONHUMAN; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; COMPLICATION; NEPHRITIS; PATHOPHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; MALE; NEPHRITIS; RATS; RATS, WISTAR; REPERFUSION INJURY; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84971483874     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/5985903     Document Type: Article

References (35)

1. E. Macedo and R. L. Mehta, "Preventing acute kidney injury, " Critical Care Clinics, vol. 31, no. 4, pp. 773-784, 2015.
2. P. Susantitaphong, D. N. Cruz, J. Cerda et al., "World incidence of AKI: ameta-analysis, " Clinical Journal of theAmerican Society of Nephrology, vol. 8, no. 9, pp. 1482-1493, 2013.
3. J. V. Bonventre and L. Yang, "Cellular pathophysiology of ischemic acute kidney injury, " Journal of Clinical Investigation, vol. 121, no. 11, pp. 4210-4221, 2011.
4. S. R. Mulay, A. Linkermann, and H. Anders, "Necroinflammation in kidney disease, " Journal of the American Society of Nephrology, vol. 27, no. 1, pp. 27-39, 2015.
5. K. J. Kelly, W. W. Williams Jr., R. B. Colvin et al., "Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury, "The Journal of Clinical Investigation, vol. 97, no. 4, pp. 1056-1063, 1996.
6. L. Li and M. D. Okusa, "Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2Aagonists, " Nature Clinical Practice Nephrology, vol. 2, no. 8, pp. 432-444, 2006.
7. S. Lee, S. Huen, H. Nishio et al., "Distinct macrophage phenotypes contribute to kidney injury and repair, " Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 317-326, 2011.
8. R. Di Paola, T. Genovese, D. Impellizzeri, A. Ahmad, S. Cuzzocrea, and E. Esposito, "Therenal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-R1: a comparison with infliximab treatment, " European Journal of Pharmacology, vol. 700, no. 1-3, pp. 134-146, 2013.
9. M. A. Glozak, N. Sengupta, X. Zhang, and E. Seto, "Acetylation and deacetylation of non-histone proteins, " Gene, vol. 363, no. 1-2, pp. 15-23, 2005.
10. F. J. Dekker, T. van den Bosch, and N. I. Martin, "Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases, " Drug Discovery Today, vol. 19, no. 5, pp. 654-660, 2014.
11. N. Liu and S. Zhuang, "Treatment of chronic kidney diseases with histone deacetylase inhibitors, " Frontiers in Physiology, vol. 6, article 121, 2015.
12. B. Monti, E. Polazzi, and A. Contestabile, "Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection, " CurrentMolecular Pharmacology, vol. 2, no. 1, pp. 95-109, 2009.
13. T. Ichiyama, K. Okada, J. M. Lipton, T. Matsubara, T. Hayashi, and S. Furukawa, "Sodium valproate inhibits production of TNF-and IL-6 and activation of NF-B, " Brain Research, vol. 857, no. 1-2, pp. 246-251, 2000.
14. Q. Zheng, W. Liu, Z. Liu, H. Zhao, X. Han, and M. Zhao, "Valproic acid protects septic mice fromrenal injury by reducing the inflammatory response, " Journal of Surgical Research, vol. 192, no. 1, pp. 163-169, 2014.
15. N. Zacharias, E. A. Sailhamer, Y. Li et al., "Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells, " Resuscitation, vol. 82, no. 1, pp. 105-109, 2011.
16. N. M. Rogers, A. W. Thomson, and J. S. Isenberg, "Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury, " Journal of the American Society of Nephrology, vol. 23, no. 9, pp. 1538-1550, 2012.
17. I. L. Noronha, S. G. Oliveira, T. S. Tavares et al., "Apoptosis in kidney and pancreas allograft biopsies, " Transplantation, vol. 79, no. 9, pp. 1231-1235, 2005.
18. H. Dellê, J. R. C. Rocha, R. C. Cavaglieri, J. M. Vieira Jr., D. M. A. C. Malheiros, and I. L. Noronha, "Antifibrotic effect of tamoxifen in a model of progressive renal disease, " Journal of the American Society of Nephrology, vol. 23, no. 1, pp. 37-48, 2012.
19. R. J. Ramalho, P. S. de Oliveira, R. C. Cavaglieri et al., "Hyperbaric oxygen therapy induces kidney protection in an ischemia/reperfusion model in rats, " Transplantation Proceedings, vol. 44, no. 8, pp. 2333-2336, 2012.
20. L. V. B. Pereira, M. H. M. Shimizu, L. P. M. R. Rodrigues, C. C. Leite, L. Andrade, and A. C. Seguro, "N-Acetylcysteine protects rats with chronic renal failure fromgadolinium-chelate nephrotoxicity, " PLoS ONE, vol. 7, no. 7, Article IDe39528, 2012.
21. R. W. Speir, J. D. Stallings, J. M. Andrews, M. S. Gelnett, T. C. Brand, and S. K. Salgar, "Effects of Valproic acid and dexamethasone administration on early bio-markers and gene expression profile in acute kidney ischemia-reperfusion injury in the rat, " PLoS ONE, vol. 10, no. 5, Article IDe0126622, 2015.
22. Z. Zhang, X. Qin, X. Zhao et al., "Valproic acid regulates antioxidant enzymes and prevents ischemia/reperfusion injury in the rat retina, " Current Eye Research, vol. 37, no. 5, pp. 429-437, 2012.
23. M. K. Tso, E. Lass, J. Ai, and R. Loch Macdonald, "Valproic acid treatment after experimental subarachnoid hemorrhage, " in Neurovascular Events after Subarachnoid Hemorrhage, J. Fandino, S. Marbacher, A.-R. Fathi, C. Muroi, and E. Keller, Eds., vol. 120 of Acta Neurochirurgica Supplement, pp. 81-85, 2015.
24. Z. Wang, L.-K. Tsai, J. Munasinghe et al., "Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke, " Stroke, vol. 43, no. 9, pp. 2430-2436, 2012.
25. R. Brar, J. P. Singh, T. Kaur, S. Arora, and A. P. Singh, "Role of GABAergic activity of sodium valproate against ischemiareperfusion-induced acute kidney injury in rats, " Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 2, pp. 143-151, 2014.
26. K. Van Beneden, C. Geers, M. Pauwels et al., "Valproic acid attenuates proteinuria and kidney injury, " Journal of the American Society of Nephrology, vol. 22, no. 10, pp. 1863-1875, 2011.
27. D.-I. Sinn, S.-J. Kim, K. Chu et al., "Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation, " Neurobiology of Disease, vol. 26, no. 2, pp. 464-472, 2007.
28. M. J. Burne, F. Daniels, A. El Ghandour et al., "Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure, " The Journal of Clinical Investigation, vol. 108, no. 9, pp. 1283-1290, 2001.
29. J. Tang, Y. Yan, T. C. Zhao et al., "Class I HDAC activity is required for renal protection and regeneration after acute kidney injury, " American Journal of Physiology-Renal Physiology, vol. 307, no. 3, pp. F303-F316, 2014.
30. S. Chateauvieux, F. Morceau, M. Dicato, and M. Diederich, "Molecular and therapeutic potential and toxicity of valproic acid, " Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 479364, 18 pages, 2010.
31. Z. Zhang, N. Tong, Y. Gong et al., "Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury, " Neuroscience Letters, vol. 504, no. 2, pp. 88-92, 2011.
32. S.-Y. Wu, S.-E. Tang, F.-C. Ko, G.-C. Wu, K.-L. Huang, and S.-J. Chu, "Valproic acid attenuates acute lung injury induced by ischemia-reperfusion in rats, " Anesthesiology, vol. 122, no. 6, pp. 1327-1337, 2015.
33. C. Wu, A. Li, Y. Leng, Y. Li, and J. Kang, "Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets, " DNA and Cell Biology, vol. 31, no. 4, pp. 592-599, 2012.
34. K. Furuichi, T. Wada, Y. Iwata et al., "CCR2 signaling contributes to ischemia-reperfusion injury in kidney, " Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2503-2515, 2003.
35. R. Kiernan, V. Brès, R. W. M. Ng et al., "Post-activation turn-off of NF-B-dependent transcription is regulated by acetylation of p65, " The Journal of Biological Chemistry, vol. 278, no. 4, pp. 2758-2766, 2003.